Castro, Elena <br/><br/>
Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  May 2013 
 - 1748-57 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2012.43.1882  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents, Hormonal--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>BRCA1 Protein--genetics<br/>BRCA2 Protein--genetics<br/>Brachytherapy<br/>Follow-Up Studies<br/>Genetic Predisposition to Disease<br/>Germ-Line Mutation<br/>Heterozygote<br/>Humans<br/>Kaplan-Meier Estimate<br/>Lymph Nodes--pathology<br/>Lymphatic Metastasis<br/>Male<br/>Middle Aged<br/>Neoplasm Grading<br/>Neoplasm Staging<br/>Nomograms<br/>Palliative Care--methods<br/>Phenotype<br/>Predictive Value of Tests<br/>Prognosis<br/>Proportional Hazards Models<br/>Prostatectomy<br/>Prostatic Neoplasms--genetics<br/>Radiotherapy, Adjuvant<br/>Retrospective Studies<br/>Risk Assessment<br/>Risk Factors